Simon Lovestone

Simon Lovestone

University of Oxford

H-index: 123

Europe-United Kingdom

About Simon Lovestone

Simon Lovestone, With an exceptional h-index of 123 and a recent h-index of 74 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of Alzheimer's disease and other neurodegenerative disorders mechanisms markers and therapies, Biomedical informatics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non‐Alzheimer's disease pathophysiology

Identification of a possible proteomic biomarker in Parkinson’s disease: Discovery and replication in blood, brain and cerebrospinal fluid

Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer’s disease in the EMIF‐AD Multimodal Biomarker Discovery study

Blood proteomics to identify AD CSF molecular subtypes

Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants

Blood-based multivariate methylation risk score for cognitive impairment and dementia

Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning

Assay for diagnosing Alzheimer's disease

Simon Lovestone Information

University

Position

Janssen and

Citations(all)

64097

Citations(since 2020)

25992

Cited By

48824

hIndex(all)

123

hIndex(since 2020)

74

i10Index(all)

429

i10Index(since 2020)

313

Email

University Profile Page

Google Scholar

Simon Lovestone Skills & Research Interests

Alzheimer's disease and other neurodegenerative disorders mechanisms markers and therapies

Biomedical informatics

Top articles of Simon Lovestone

Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non‐Alzheimer's disease pathophysiology

Alzheimer's & Dementia

2023/3

Identification of a possible proteomic biomarker in Parkinson’s disease: Discovery and replication in blood, brain and cerebrospinal fluid

Brain communications

2023/2/1

Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer’s disease in the EMIF‐AD Multimodal Biomarker Discovery study

Alzheimer's & Dementia

2023/12

Blood proteomics to identify AD CSF molecular subtypes

Alzheimer's & Dementia

2023/12

Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants

Molecular Neurodegeneration

2023/11/28

Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning

Genome medicine

2023/10/4

Assay for diagnosing Alzheimer's disease

2023/9/5

iPSC-Astrocyte morphology reflects patient clinical markers

bioRxiv

2023

Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN‐derived networks and highlights causal links in Alzheimer's disease

Alzheimer's & Dementia

2023/8

Whole‐exome rare‐variant analysis of Alzheimer's disease and related biomarker traits

Alzheimer's & Dementia

2023/6

IPSC‐derived neurons with amyloid‐β treatment reflect features of Alzheimer’s disease patients

Alzheimer's & Dementia

2023/6

Predicting progression to Alzheimer’s disease with human hippocampal progenitors exposed to serum

Brain

2023/5/2

Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease

Journal of Neuroinflammation

2023/4/9

Multiomics machine learning identifies sleep and inflammation molecular pathways in prodromal Alzheimer′ s Disease

2023/3/6

Genome-wide association study of Alzheimer’s disease brain imaging biomarkers and neuropsychological phenotypes in the European medical information framework for Alzheimer’s …

Frontiers in aging neuroscience

2022/3/21

Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

2022

Genome‐and epigenome‐wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

2022

Liu Shi
Liu Shi

H-Index: 6

Simon Lovestone
Simon Lovestone

H-Index: 71

Effect of trazodone on cognitive decline in people with dementia: Cohort study using UK routinely collected data

International Journal of Geriatric Psychiatry

2022/1

See List of Professors in Simon Lovestone University(University of Oxford)